Neurotrope, Inc. is a biopharmaceutical company dedicated to pioneering innovative therapies for Alzheimer’s disease. Based in New York, the firm is advancing a proprietary product platform aimed at addressing the unmet medical needs associated with neurodegenerative disorders. With a strong focus on research and development, Neurotrope is positioned to potentially reshape the landscape of Alzheimer's treatment, presenting robust opportunities for institutional investors in a critical healthcare sector.
Click "Analyze" to generate stock analysis
NTRP Price Trend and Signals
NTRP Financials
2025-10-28Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-24Bullishmacd_signal
Golden cross below zero detected.
2025-10-24Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-24Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-24Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-24Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.